The effects of Vitex agnus-castus supplementation on inflammatory markers in women with PCOS: a randomized, double-blind, placebocontrolled trial
Research in Pharmaceutical Sciences · 2026-03 · 21 (2) · 206-214
DOI: 10.4103/rps.rps_152_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Pharmaceutical Sciences, online erschienen am 24.04.2026. Verfasst von Aniseh Hatami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Arak University of Medical Sciences, Arak, Iran. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose: To evaluate the effects of Vitex agnus-castus supplementation on serum levels of inflammatory cytokines (primary outcomes: tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6); secondary outcome: anti-Mullerian hormone (AMH)) in women with polycystic ovary syndrome (PCOS). Experimental approach: This secondary analysis included 40 serum samples (20 Vitex and 20 placebo) randomly selected from a previously registered randomized, double-blind, placebo-controlled trial in women with PCOS. Participants received either Vitex (5.8 mg/day, standardized to 0.42-0.82 mg aucubin) or a placebo for 12 weeks. Serum TNF-α, IL-6, and AMH were measured at baseline and week 12 using ELISA. Within- group changes were assessed with paired t-tests, and between-group differences were analyzed using independent t-tests and ANCOVA using SPSS v23.0 software. Findings/Results: Vitex supplementation significantly reduced serum TNF-α (141.27 ± 24.27 to 91.28 ± 19.57 pg/mL), IL-6 (71.72 ± 13.63 to 48.91 ± 24.19 pg/mL), and AMH (11.21 ± 3.89 to 7.88 ± 4.87 ng/mL) levels, whereas the placebo group showed no significant changes. The between-group differences were significant for all markers. These findings suggest potential benefits in reducing inflammation and improving ovarian function, pending confirmation in future clinical outcome studies. Conclusion and implications: Vitex supplementation may offer a complementary approach to managing inflammation and hormonal disturbances in women with PCOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
- Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
- Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran.
- Department of Obstetrics and Gynecology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Zitieren
APA
Hatami, A., Taheri, H., Khosrowbeygi, A., Seidi, F., Azimi, M., & Jalali-Mashayekhi, F. (2026). The effects of Vitex agnus-castus supplementation on inflammatory markers in women with PCOS: a randomized, double-blind, placebocontrolled trial. Research in Pharmaceutical Sciences, 21(2), 206-214. https://doi.org/10.4103/rps.rps_152_25
Vancouver
Hatami A, Taheri H, Khosrowbeygi A, Seidi F, Azimi M, Jalali-Mashayekhi F. The effects of Vitex agnus-castus supplementation on inflammatory markers in women with PCOS: a randomized, double-blind, placebocontrolled trial. Research in Pharmaceutical Sciences. 2026;21(2):206-214. doi:10.4103/rps.rps_152_25
BibTeX
@article{Hatami2026,
author = {Hatami, Aniseh and Taheri, Hanieh and Khosrowbeygi, Ali and Seidi, Fateme and Azimi, Mohadeseh and Jalali-Mashayekhi, Farideh},
title = {The effects of Vitex agnus-castus supplementation on inflammatory markers in women with PCOS: a randomized, double-blind, placebocontrolled trial},
journal = {Research in Pharmaceutical Sciences},
year = {2026},
volume = {21},
number = {2},
pages = {206--214},
doi = {10.4103/rps.rps_152_25}
}
EUVIMED